News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
334,332 Results
Type
Article (19491)
Company Profile (117)
Press Release (314724)
Multimedia
Podcasts (49)
Webinars (11)
Section
Business (104961)
Career Advice (739)
Deals (18338)
Drug Delivery (83)
Drug Development (44442)
Employer Resources (65)
FDA (8148)
Job Trends (7860)
News (179717)
Policy (16461)
Tag
Academia (935)
Accelerated approval (2)
Adcomms (12)
Allergies (42)
Alliances (28771)
ALS (57)
Alzheimer's disease (745)
Antibody-drug conjugate (ADC) (54)
Approvals (8183)
Artificial intelligence (184)
Autoimmune disease (14)
Automation (11)
Bankruptcy (165)
Best Places to Work (5819)
BIOSECURE Act (11)
Biosimilars (62)
Biotechnology (53)
Bladder cancer (33)
Brain cancer (20)
Breast cancer (102)
Cancer (955)
Cardiovascular disease (95)
Career advice (631)
Career pathing (14)
CAR-T (66)
Cell therapy (191)
Cervical cancer (7)
Clinical research (37150)
Collaboration (538)
Compensation (182)
Complete response letters (17)
COVID-19 (1265)
CRISPR (30)
C-suite (163)
Cystic fibrosis (47)
Data (1043)
Denatured (16)
Depression (31)
Diabetes (113)
Diagnostics (2639)
Digital health (5)
Diversity (2)
Diversity, equity & inclusion (13)
Drug discovery (80)
Drug pricing (70)
Drug shortages (12)
Duchenne muscular dystrophy (47)
Earnings (38108)
Editorial (19)
Employer branding (6)
Employer resources (58)
Events (45704)
Executive appointments (519)
FDA (8796)
Friedreich's ataxia (2)
Frontotemporal dementia (5)
Funding (378)
Gene editing (59)
Generative AI (15)
Gene therapy (168)
GLP-1 (423)
Government (1733)
Grass and pollen (3)
Guidances (50)
Healthcare (6206)
Huntington's disease (13)
IgA nephropathy (18)
Immunology and inflammation (50)
Indications (19)
Infectious disease (1313)
Inflammatory bowel disease (75)
Inflation Reduction Act (6)
Influenza (21)
Intellectual property (62)
Interviews (98)
IPO (7218)
IRA (29)
Job creations (2288)
Job search strategy (550)
Kidney cancer (8)
Labor market (16)
Layoffs (218)
Leadership (7)
Legal (3818)
Liver cancer (31)
Lung cancer (135)
Lymphoma (76)
Machine learning (4)
Management (22)
Manufacturing (262)
MASH (42)
Medical device (3535)
Medtech (3538)
Mergers & acquisitions (11414)
Metabolic disorders (345)
Multiple sclerosis (43)
NASH (15)
Neurodegenerative disease (58)
Neuropsychiatric disorders (18)
Neuroscience (1090)
NextGen: Class of 2025 (2358)
Non-profit (1158)
Now hiring (8)
Obesity (188)
Opinion (146)
Ovarian cancer (27)
Pain (69)
Pancreatic cancer (29)
Parkinson's disease (83)
Partnered (12)
Patents (149)
Patient recruitment (43)
Peanut (14)
People (33487)
Pharmaceutical (65)
Pharmacy benefit managers (14)
Phase I (9838)
Phase II (16120)
Phase III (13797)
Pipeline (675)
Policy (79)
Postmarket research (1555)
Preclinical (4001)
Press Release (34)
Prostate cancer (60)
Psychedelics (17)
Radiopharmaceuticals (161)
Rare diseases (224)
Real estate (3299)
Recruiting (27)
Regulatory (11967)
Reports (17)
Research institute (963)
Resumes & cover letters (123)
Rett syndrome (2)
RNA editing (2)
RSV (8)
Schizophrenia (58)
Series A (68)
Series B (43)
Service/supplier (5)
Sickle cell disease (41)
Special edition (8)
Spinal muscular atrophy (109)
Sponsored (16)
Startups (1971)
State (2)
Stomach cancer (3)
Supply chain (43)
Tariffs (36)
The Weekly (31)
Vaccines (247)
Venture capitalists (18)
Weight loss (129)
Women's health (14)
Worklife (8)
Date
Today (92)
Last 7 days (401)
Last 30 days (1371)
Last 365 days (16120)
2025 (5656)
2024 (17147)
2023 (19391)
2022 (25957)
2021 (27232)
2020 (25790)
2019 (20712)
2018 (15698)
2017 (17099)
2016 (16285)
2015 (18877)
2014 (14830)
2013 (12511)
2012 (13348)
2011 (14055)
2010 (12551)
Location
Africa (413)
Alabama (22)
Alaska (6)
Arizona (71)
Arkansas (5)
Asia (24088)
Australia (3370)
California (2688)
Canada (1145)
China (304)
Colorado (105)
Connecticut (115)
Delaware (83)
Europe (49066)
Florida (460)
Georgia (70)
Idaho (15)
Illinois (260)
India (22)
Indiana (171)
Iowa (2)
Japan (110)
Kansas (68)
Kentucky (15)
Louisiana (2)
Maine (4)
Maryland (372)
Massachusetts (2160)
Michigan (94)
Minnesota (129)
Mississippi (1)
Missouri (31)
Montana (12)
Nebraska (10)
Nevada (22)
New Hampshire (11)
New Jersey (961)
New Mexico (23)
New York (808)
North Carolina (571)
North Dakota (4)
Northern California (1145)
Ohio (99)
Oklahoma (7)
Oregon (23)
Pennsylvania (609)
Puerto Rico (9)
Rhode Island (13)
South America (611)
South Carolina (4)
Southern California (1047)
Tennessee (46)
Texas (402)
United States (10736)
Utah (84)
Virginia (118)
Washington D.C. (38)
Washington State (227)
West Virginia (2)
Wisconsin (33)
334,332 Results for "sca pharmaceuticals".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Lone Star Bio
Renibus Therapeutics Announces Oral Presentations on RBT-1 at AATS and SCA Medical Conferences
Renibus Therapeutics® today announced its participation at two prestigious medical conferences: the American Association for Thoracic Surgery (AATS) 104th Annual Meeting and the Society of Cardiovascular Anesthesiologists (SCA) 46th Annual Meeting, both taking place in Toronto, Canada, April 27-30, 2024.
April 26, 2024
·
4 min read
Business
SCA Pharma Names Hugh O’Neill as Chief Commercial Officer
SCA Pharma, a nationally recognized leader in the 503B compounding pharmaceuticals outsourcing industry providing quality, service, and value to hospitals nationwide, has announced the addition of Hugh O’Neill as Chief Commercial Officer.
March 9, 2023
·
2 min read
Pharm Country
SCA Pharma Awarded Multi-Year Contract with Vizient, Supporting Better Drug Accessibility
SCA Pharma, a nationally recognized leader in the 503B compounded pharmaceuticals outsourcing industry, providing quality, service, and value to hospitals nationwide, has announced that Vizient has awarded a multi-year agreement to the company for its full range of 503B ready-to-use products.
November 1, 2022
·
2 min read
Pharm Country
SCA Pharma Names Louis Pace as Chief Financial Officer and Chief Information Officer
SCA Pharma, a nationally recognized leader in the 503B compounding pharmaceuticals outsourcing industry providing quality, service, and value to hospitals nationwide, has announced the addition of Louis Pace as Chief Financial Officer and Chief Information Officer.
July 14, 2022
·
1 min read
Press Releases
Faraday Pharmaceuticals to Host Satellite Symposium at SCAI 2025 on Exploring New Frontiers in Reducing Ischemia-Reperfusion Injury
April 25, 2025
·
5 min read
Drug Development
Biohaven Provides Update on Phase 3 Clinical Trial Evaluating Troriluzole for Spinocerebellar Ataxia (SCA)
Biohaven Pharmaceutical Holding Company Ltd. (NYSE: BHVN) today announced top-line results from a Phase 3 clinical trial evaluating the efficacy and safety of its investigational therapy, troriluzole, in patients with spinocerebellar ataxia (SCA).
May 23, 2022
·
7 min read
Press Releases
Hanmi Pharmaceutical’s ‘Gugutams’ to be Launched in Mexico as ‘Aditams’, Marking the Start of Full-Scale Latin America Expansion
April 2, 2025
·
3 min read
Press Releases
Mallinckrodt and Endo to Combine to Create a Global, Scaled, Diversified Pharmaceuticals Leader
March 13, 2025
·
28 min read
Pharm Country
The Vistria Group and Excellere Partners Invest in SCA Pharmaceuticals
SCA Pharmaceuticals, LLC, has entered into a definitive membership interest purchase agreement with The Vistria Group and Excellere Partners.
January 21, 2021
·
4 min read
Press Releases
Arrowhead Pharmaceuticals Announces Closing of Global License and Collaboration Agreement with Sarepta Therapeutics
February 10, 2025
·
6 min read
1 of 33,434
Next
